17901413

Source:http://linkedlifedata.com/resource/pubmed/id/17901413

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0034656, umls-concept:C0252643, umls-concept:C1800706
pubmed:issue	1
pubmed:dateCreated	2007-12-21
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00071461
pubmed:abstractText	Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal lung disease lacking effective treatment.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/17901413-18363525
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9421642
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/bosentan
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1535-4970
pubmed:author	pubmed-author:BehrJürgenJ, pubmed-author:BrownKevin KKK, pubmed-author:KingTalmadge ETEJr, pubmed-author:LancasterLisaL, pubmed-author:LeconteIsabelleI, pubmed-author:RaghuGaneshG, pubmed-author:RouxSébastienS, pubmed-author:StählerGerdG, pubmed-author:de AndradeJoao AJA, pubmed-author:du BoisRoland MRM
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	177
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	75-81
pubmed:dateRevised	2008-4-18
pubmed:meshHeading	pubmed-meshheading:17901413-Administration, Oral, pubmed-meshheading:17901413-Aged, pubmed-meshheading:17901413-Antihypertensive Agents, pubmed-meshheading:17901413-Disease Progression, pubmed-meshheading:17901413-Dose-Response Relationship, Drug, pubmed-meshheading:17901413-Double-Blind Method, pubmed-meshheading:17901413-Drug Administration Schedule, pubmed-meshheading:17901413-Exercise Test, pubmed-meshheading:17901413-Female, pubmed-meshheading:17901413-Forced Expiratory Volume, pubmed-meshheading:17901413-Humans, pubmed-meshheading:17901413-Long-Term Care, pubmed-meshheading:17901413-Male, pubmed-meshheading:17901413-Middle Aged, pubmed-meshheading:17901413-Prospective Studies, pubmed-meshheading:17901413-Pulmonary Fibrosis, pubmed-meshheading:17901413-Quality of Life, pubmed-meshheading:17901413-Sulfonamides, pubmed-meshheading:17901413-Survival Rate, pubmed-meshheading:17901413-Tomography, Spiral Computed, pubmed-meshheading:17901413-Treatment Outcome, pubmed-meshheading:17901413-Vital Capacity
pubmed:year	2008
pubmed:articleTitle	BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.
pubmed:affiliation	Department of Medicine, UCSF, 505 Parnassus Avenue, Room M994, San Francisco, CA 94110, USA. tking@medicine.ucsf.edu
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study